Given the large role PPARs have in many lifestyle-related diseases, such as obesity and diabetes, further studies of the CB2-PPARγ crosstalk could place serious groundwork for a better understanding of the impact that the ECS could have on these diseases and their complications. This evidence concerns the gene PPARG and obesity disorder.